JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kao, C. Y.
Right arrow Articles by Fuhrman, F. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kao, C. Y.
Right arrow Articles by Fuhrman, F. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 140, Issue 1, 31-40, 1963
Copyright © 1963 by American Society for Pharmacology and Experimental Therapeutics


PHARMACOLOGICAL STUDIES ON TARICHATOXIN, A POTENT NEUROTOXIN

C. Y. Kao 1 and Frederick A. Fuhrman 1

1 Max C. Fleischmann Laboratories of the Medical Sciences, Stanford University School of Medicine, Palo Alto, California, and Department of Pharmacology, State University of New York, Downstate Medical Center, Brooklyn, New York

Tarichatoxin, a purified substance with the probable molecular formula of C11H17N3O8 can be obtained from the eggs of the California salamander, Taricha torosa. Upon parenteral administration in doses of 1.4 to 3 µg/kg to anesthetized cats, tarichatoxin caused profound hypotension and weakness of neurally elicited contractions of the nictitating membrane and skeletal muscles. The minimum lethal dose in mice was about 8 µg/kg and LD50 about 10 µg/kg, death being preceded by clonic convulsions and paralysis of skeletal and respiratory muscles. In a concentration of 5 mg/l the toxin produced corneal anesthesia of short duration in the rabbit's eye. Action potentials of the desheathed frog nerve were readily blocked by tarichatoxin. A concentration of 1 µg/l (0.003 µM) produced partial block while a concentration of 10 µg/l (0.03 µM) produced complete block. The axonal block was not preceded, accompanied, or followed by any change in the resting potential. The concentrations required to produce axonal block in vitro are in agreement with those producing systemic effects if the tarichatoxin is assumed to be homogeneously distributed in the body water. Since the cholinergic and adrenergic receptors in the autonomic ganglia and in the various effector cells are not affected by tarichatoxin, almost all the systemic effects produced by tarichatoxin can be ascribed to a block of the preganglionic cholinergic and the somatic motor nerves. Tarichatoxin is some 160,000 times more potent than cocaine in producing axonal block. Its pharmacological properties are compared with those of saxitoxin and tetrodotoxin.

Submitted on September 24, 1962
Accepted on December 26, 1962




This article has been cited by other articles:


Home page
Biol. Bull.Home page
R. K. Zimmer and R. P. Ferrer
Neuroecology, Chemical Defense, and the Keystone Species Concept
Biol. Bull., December 1, 2007; 213(3): 208 - 225.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. D. Buchwald, L. Durham, H. G. Fischer, R. Harada, H. S. Mosher, C. Y. Kao, and F. A. Fuhrman
Identity of Tarichatoxin and Tetrodotoxin
Science, January 31, 1964; 143(3605): 474 - 475.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1963 by the American Society for Pharmacology and Experimental Therapeutics.